- Previous Close
826.00 - Open
804.00 - Bid 816.00 x --
- Ask 818.00 x --
- Day's Range
804.00 - 837.00 - 52 Week Range
791.00 - 1,739.00 - Volume
247,096 - Avg. Volume
300,821 - Market Cap (intraday)
586.833M - Beta (5Y Monthly) 1.08
- PE Ratio (TTM)
22.11 - EPS (TTM)
0.37 - Earnings Date Feb 27, 2025
- Forward Dividend & Yield 0.08 (0.97%)
- Ex-Dividend Date Oct 31, 2024
- 1y Target Est
1,506.62
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through Veterinary Practices, Laboratories, Crematoria, and Online Retail Business segments. It operates in animal veterinary practices and complementary veterinary diagnostic businesses. In addition, the company provides pet cremation and clinical waste disposal services for veterinary practices. CVS Group plc operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products; and an online dispensary. Further, the company provides burial grounds; veterinary instrumentation supply; and property development services. CVS Group plc owns veterinary practices, laboratories, and crematories in the United Kingdom, Australia, the Netherlands, and the Republic of Ireland. The company was founded in 1999 and is headquartered in Diss, the United Kingdom.
www.cvsukltd.co.uk8,822
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: CVSG.L
View MorePerformance Overview: CVSG.L
Trailing total returns as of 1/14/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CVSG.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CVSG.L
View MoreValuation Measures
Market Cap
592.57M
Enterprise Value
863.87M
Trailing P/E
22.63
Forward P/E
8.88
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.91
Price/Book (mrq)
2.28
Enterprise Value/Revenue
1.33
Enterprise Value/EBITDA
7.97
Financial Highlights
Profitability and Income Statement
Profit Margin
0.96%
Return on Assets (ttm)
5.03%
Return on Equity (ttm)
10.21%
Revenue (ttm)
647.3M
Net Income Avi to Common (ttm)
26.2M
Diluted EPS (ttm)
0.37
Balance Sheet and Cash Flow
Total Cash (mrq)
16.5M
Total Debt/Equity (mrq)
110.48%
Levered Free Cash Flow (ttm)
31.07M